StockData
Instil Bio, Inc. logo

Instil Bio, Inc. (TIL) stock

TILNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$5.43+0.03 (+0.56%)

Close on Nov 18, 2026Market cap $36.83MP/E –Yield –

Instil Bio gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

No gross profit figures for Instil Bio

Instil Bio has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Instil Bio figures

See a number that looks wrong?